Navigation Links
Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Date:10/9/2007

Phase 2 Drug Candidate Protects the Ocular Surface Following Exposure to

Controlled Adverse Environment, Reduces Dry Eye Symptoms

LAGUNA HILLS, Calif., Oct. 9 /PRNewswire/ -- Alacrity Biosciences today announced that its dry eye treatment, ALTY-0501, demonstrated statistically significant advantages over vehicle in its ability to control signs and symptoms of dry eye in a Phase 2 study.

The Phase 2 study utilized the controlled adverse environment (CAE) chamber to measure dry eye patients' ability to withstand a stressful drying environment on the eye, and patient diaries to measure the severity of their dry eye symptoms over the course of the study. Patients were randomized to receive ALTY-0501 or its vehicle four times each day over the course of a 56 day study.

Patients who received ALTY-0501 demonstrated statistically significantly lower scores following CAE exposure for fluorescein staining of the total cornea-a measure of damage to the ocular surface-than those who received vehicle (p < 0.05) on day 28. Statistically significant differences from vehicle were also observed with total corneal and conjunctival staining (p < 0.05), superior corneal staining (p < 0.001) and nasal conjunctival staining (p < 0.05).

ALTY-0501 also demonstrated statistically significant advantages compared to vehicle in the patient diary scores measuring the severity of dry eye symptoms over the 56-day study period. Specifically, patient diary scores reflected statistically significantly lower scores for the symptoms of burning (p < 0.0001), stinging (p < 0.0001), and grittiness (p < 0.0001) in the active treated group.

"We have strong evidence that ALTY-0501 can help control patient signs and symptoms by maintaining the epithelial barrier on the surface of the eye," said David F. Power, Alacrity's president and CEO. "We plan to discuss the Phase 2 data and confirm our Phase 2b/3 strategy with the FDA in the fourth quarter of 2007. Our in
'/>"/>

SOURCE Alacrity Biosciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
5. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
9. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
10. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  Daktari Diagnostics was honored at the ... in the Service of Society Award. IEEE President and CEO, ... L. Shoop presented the award to Principal Scientist ... was held Saturday, June 20, 2015, at the historic Waldorf ... "I have spent more than 3 years ...
(Date:6/29/2015)... ZIONA, Israel , June 29, 2015 ... TASE: BVXV) today announced positive preliminary results from its ... for a universal influenza vaccine. In this trial, M-001 ... 50 to 65, followed by an administration of the ... M-001 was found to be safe and well tolerated ...
(Date:6/29/2015)... , June 29, 2015 Regeneron Pharmaceuticals, ... the Proceedings of the National Academy of ... that the Company,s proprietary VelociGene ® and ... and preclinical validation of potential candidates that could ... Middle East Respiratory Syndrome (MERS). This involved the ...
Breaking Medicine Technology:Daktari Honored with IEEE Spectrum Award 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... MedVantx, Inc., the company that created first ever controlled access ... Inc. Magazine has rated the company as one of the ... year in a row, MedVantx has made the list.  In ... thirteenth overall. The Inc. 500/5000 list is the ...
... 2011 CORPAK MedSystems, Inc., a leading ... enteral feeding and bedside-technology markets, today announced the appointment ... officer. Mr. Blair brings 40 years ... recently as the chairman and chief executive officer of ...
Cached Medicine Technology:MedVantx Honored by Inc. 500/5000 Three Years in a Row 2CORPAK MedSystems Names Jeffrey Blair Chief Executive Officer 2CORPAK MedSystems Names Jeffrey Blair Chief Executive Officer 3
(Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, ... Peacock Alley story including hard work, tenacity, perseverance, commitment to quality, honesty and love ... , Born of Mary Ella Gabler's simple love of quilts, Peacock Alley was fully ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. ... the nation’s leading networking organization exclusively for professional women, boasting more than 700,000 ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... November at one of the industry’s premier thought leadership symposiums, “Harmony 2015” hosted ... of nursing, rehabilitation managers and other management and corporate personnel representing the skilled ...
(Date:6/29/2015)... , ... June 30, 2015 , ... The United ... Rehab Team (KORT) as it becomes the Official Physical and Occupational Therapists of the ... 2015 Rolex Kentucky Three-Day Event presented by Land Rover. , “The USEF is ...
Breaking Medicine News(10 mins):Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2
... leading e-learning provider and a division of Futuremedia ... a next,generation personalised learning environment, for Bupa, the ... place at Bupa offices in Manchester and Staines ... support and overviews,of the portal,s features to Bupa ...
... Omega-3 +Plus Snack String Cheese from Sorrento(R) joins +Plus line of ... ... April 21 As consumers continue to be,increasingly health-conscious and functional ... that provide,health benefits beyond basic nutrition to meet consumer demand. In ...
... today reported that Novartis AG announced global sales of ... ended,March 31, 2008. This represents a decrease of 40.4% ... the U.S. were $9.3 million, up 10.6% from the,prior-year ... million,down 48.5% from the prior year. The drop in ...
... to be Opened in the North West of England -, ... ORCH ), a leading worldwide provider of identity DNA testing,services, ... in the North West of England later this year following ... work was awarded to Orchid,Cellmark following the North West/South West ...
... and ... ... Inc. (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced that ... Dr. Weber brings a wealth of experience to this position, ...
... provider of,Business Process Outsourcing solutions for health payers, ... and URL address. The new company website,is now ... also been refreshed,with useful information to help health ... business process outsourcing services., (Logo: http://www.newscom.com/cgi-bin/prnh/20050113/SFTH042LOGO ...
Cached Medicine News:Health News:Futuremedia Learning Launches Next Generation Learning Portal for Bupa 2Health News:Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market 2Health News:Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market 3Health News:QLT announces first quarter 2008 Visudyne(R) sales 2Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 2Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 3Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 4Health News:Bioniche Appoints U.S. President of Food Safety 2Health News:Bioniche Appoints U.S. President of Food Safety 3Health News:Bioniche Appoints U.S. President of Food Safety 4Health News:Adaptis Launches New Website and URL Address 2